Tiaa, Fsb Pulse Biosciences, Inc. Transaction History

Tiaa, Fsb

$27.6 Billion
Q2 2023

A detailed history of Tiaa, Fsb transactions in Pulse Biosciences, Inc. stock. As of the latest transaction made, Tiaa, Fsb holds 27,298 shares of PLSE stock, worth $469,525. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,298

Previous 27,298 -0.0%

Holding current value

$469,525

Previous $91,000 115.38%

% of portfolio

0.0%

Previous 0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$1.48 - $4.28 $40,401 - $116,835	27,298 New	27,298 $42,000
Q1 2022 Apr 13, 2022	SELL	$4.21 - $14.79 $114,924 - $403,737	-27,298 Closed	0 $0
Q2 2020 Jul 15, 2020	BUY	$6.23 - $13.09 $170,066 - $357,330	27,298 New	27,298 $286,000
Q1 2020 Apr 21, 2020	SELL	$5.23 - $15.2 $142,768 - $414,929	-27,298 Closed	0 $0
Q4 2018 Apr 15, 2019	BUY	$9.08 - $14.34 $247,865 - $391,453	27,298 New	27,298 $313,000
Q4 2018 Feb 22, 2019	SELL	$9.08 - $14.34 $247,865 - $391,453	-27,298 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$10.26 - $24.97 $280,077 - $681,631	27,298	27,298 $508,000

Others Institutions Holding PLSE

# of Institutions

Shares Held

4.78M

Call Options Held

138K

Put Options Held

96.2K

View Full List

About Pulse Biosciences, Inc.

Ticker PLSE
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,125,900
Market Cap $639M
Description
Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using it...

More about PLSE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiaa, Fsb, based on Form 13F filings with the SEC.

News

Stay updated on Tiaa, Fsb with notifications on news.

Account